Schedule 13G ownership disclosure

Acer Therapeutics Inc.

Security class unavailable · CUSIP: 00444P108

Event date: 2020-05-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-004964
Form type
SC 13G
Filer
Acer Therapeutics Inc.
CIK
CIK 1069308
Filed
May 19, 2020
Reporting period
May 14, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub